SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 29 filers reported holding SEELOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $72,000 | -53.5% | 29,690 | -4.4% | 0.00% | -100.0% |
Q1 2021 | $155,000 | -39.5% | 31,060 | -80.8% | 0.00% | -50.0% |
Q4 2020 | $256,000 | +2744.4% | 161,804 | +831.3% | 0.00% | – |
Q1 2020 | $9,000 | -67.9% | 17,374 | -18.0% | 0.00% | – |
Q4 2019 | $28,000 | +33.3% | 21,200 | -9.1% | 0.00% | – |
Q3 2019 | $21,000 | -66.7% | 23,330 | -18.5% | 0.00% | -100.0% |
Q2 2019 | $63,000 | – | 28,629 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 508,000 | $249,000 | 0.10% |
1492 Capital Management LLC | 150,000 | $74,000 | 0.09% |
Uniplan Investment Counsel, Inc. | 2,069,121 | $1,014,000 | 0.08% |
ARDSLEY ADVISORY PARTNERS LP | 70,000 | $34,000 | 0.01% |
Spark Investment Management LLC | 35,210 | $17,000 | 0.01% |
TOCQUEVILLE ASSET MANAGEMENT L.P. | 191,000 | $94,000 | 0.00% |
WealthPLAN Partners, LLC | 20,000 | $15,000 | 0.00% |
Procyon Advisors, LLC | 2,500 | $1,000 | 0.00% |
Renaissance Technologies | 1,078,379 | $529,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |